These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3631764)

  • 41. Hyperosmolality in the burn patient: analysis of an osmolal discrepancy.
    Kulick MI; Lewis NS; Bansal V; Warpeha R
    J Trauma; 1980 Mar; 20(3):223-8. PubMed ID: 7359597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Burn wound management.
    Davies MR; Rode H; Cywes S; van der Riet RL
    Prog Pediatr Surg; 1981; 14():33-61. PubMed ID: 7012931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pattern and outcome of burn injuries at Wesley Guild Hospital, Ilesha, Nigeria: a review of 156 cases.
    Adesunkanmi K; Oyelami OA
    J Trop Med Hyg; 1994 Apr; 97(2):108-12. PubMed ID: 8170000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical silver sulphadiazine: side effects and urinary excretion.
    Lockhart SP; Rushworth A; Azmy AA; Raine PA
    Burns Incl Therm Inj; 1983 Sep; 10(1):9-12. PubMed ID: 6640389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serum and tissue silver levels after burns treated with silver compounds].
    Kartal A; Tatkan Y; Belviranli M; Sahin M; Duman S; Karahan O; Gurbilek M; Temur S
    J Chir (Paris); 1989 Dec; 126(12):676-81. PubMed ID: 2621235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.
    Disanti W; Rajapakse RO; Korelitz BI; Panagopoulos G; Bratcher J
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1025-9. PubMed ID: 16765651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical observation of the efficacy of MEBO in the treatment of burn patients with burn area over 50% TBSA].
    Hu YC; Ou CS; Huang ZC; Xu XS; Li ZX; Luo LY
    Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):57-60. PubMed ID: 16680965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moist Exposed Burn Ointment (MEBO) in partial thickness burns - a randomized, comparative open mono-center study on the efficacy of dermaheal (MEBO) ointment on thermal 2nd degree burns compared to conventional therapy.
    Hirsch T; Ashkar W; Schumacher O; Steinstraesser L; Ingianni G; Cedidi CC
    Eur J Med Res; 2008 Nov; 13(11):505-10. PubMed ID: 19073386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central line-related sepsis in acute burn patients.
    Still JM; Law E; Thiruvaiyaru D; Belcher K; Donker K
    Am Surg; 1998 Feb; 64(2):165-70. PubMed ID: 9486891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical cerium nitrate prevents postburn immunosuppression.
    Peterson VM; Hansbrough JF; Wang XW; Zapata-Sirvent R; Boswick JA
    J Trauma; 1985 Nov; 25(11):1039-44. PubMed ID: 4057291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cutaneous absorption and urinary elmination of a silver sulfadiazine compound used in the treatment of burns].
    Delaveau P; Friedrich-Noue P
    Therapie; 1977; 32(5):563-72. PubMed ID: 613473
    [No Abstract]   [Full Text] [Related]  

  • 53. A prospective analysis of silver sulfadiazine with and without cerium nitrate as a topical agent in the treatment of severely burned children.
    Bowser BH; Caldwell FT; Cone JB; Eisenach KD; Thompson CH
    J Trauma; 1981 Jul; 21(7):558-63. PubMed ID: 7019454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective study of side effects associated with the use of silver sulfadiazine in severely burned patients.
    Kulick MI; Wong R; Okarma TB; Falces E; Berkowitz RL
    Ann Plast Surg; 1985 May; 14(5):407-19. PubMed ID: 4083697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical silver sulphadiazine and profound neutropenia in a burned child.
    Wilson P; George R; Raine P
    Burns Incl Therm Inj; 1986 Apr; 12(4):295-6. PubMed ID: 3719408
    [No Abstract]   [Full Text] [Related]  

  • 56. Absorption, excretion and tissue distribution of silver sulphadiazine.
    Sano S; Fujimori R; Takashima M; Itokawa Y
    Burns Incl Therm Inj; 1982 Mar; 8(4):278-85. PubMed ID: 7066727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silver serum levels in burned patients treated with silver sulfadiazine and its toxicity on inflammatory cells.
    Mimura ECM; Favoreto JPM; Favero ME; Bonifacio KL; Peixe TS; Morita AA; Barbosa DS; Yabe MJS; Carrilho AJF
    Burns; 2020 Aug; 46(5):1120-1127. PubMed ID: 31839506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed management of giant omphalocele using silver sulfadiazine cream: an 18-year experience.
    Ein SH; Langer JC
    J Pediatr Surg; 2012 Mar; 47(3):494-500. PubMed ID: 22424344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient.
    Eldad A; Neuman A; Weinberg A; Benmeir P; Rotem M; Wexler MR
    Burns; 1991 Oct; 17(5):430-2. PubMed ID: 1760119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective study of thymopentin in severely burned patients.
    Waymack JP; Jenkins M; Warden GD; Solomkin J; Law E; Hummel R; Miller A; Alexander JW
    Surg Gynecol Obstet; 1987 May; 164(5):423-30. PubMed ID: 3554564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.